2025
Protocol for finding genetic variation associated with unmeasured traits through GenomicSEM common-factor GWAS
Johnston K, Signer R, Huckins L. Protocol for finding genetic variation associated with unmeasured traits through GenomicSEM common-factor GWAS. STAR Protocols 2025, 6: 103905. PMID: 40531628, PMCID: PMC12213288, DOI: 10.1016/j.xpro.2025.103905.Peer-Reviewed Original Research
2024
Chronic overlapping pain conditions and nociplastic pain
Johnston K, Signer R, Huckins L. Chronic overlapping pain conditions and nociplastic pain. Human Genetics And Genomics Advances 2024, 6: 100381. PMID: 39497418, PMCID: PMC11617767, DOI: 10.1016/j.xhgg.2024.100381.Peer-Reviewed Original ResearchGenome wide association studiesTranscriptome-wide associationChronic overlapping pain conditionsTissue enrichment analysisSingle nucleotide polymorphismsEnrichment analysisNociplastic painPain conditionsIndependent single nucleotide polymorphismsMultisite chronic painGene Set Enrichment AnalysisSNP heritabilityUnique genesNeuropathic pain phenotypesAssociation studiesPolygenic traitChronic pain conditionsGene setsNucleotide polymorphismsMetabolic traitsHeritable traitGenetic overlapPain phenotypesPain descriptorsPain experience
2023
TRPA1 rare variants in chronic neuropathic and nociplastic pain patients
Marchi M, Salvi E, Andelic M, Mehmeti E, D'Amato I, Cazzato D, Chiappori F, Lombardi R, Cartelli D, Devigili G, Bella E, Gerrits M, Almomani R, Malik R, Ślęczkowska M, Mazzeo A, Gentile L, Dib-Hajj S, Waxman S, Faber C, Vecchio E, de Tommaso M, Lauria G. TRPA1 rare variants in chronic neuropathic and nociplastic pain patients. Pain 2023, 164: 2048-2059. PMID: 37079850, PMCID: PMC10443199, DOI: 10.1097/j.pain.0000000000002905.Peer-Reviewed Original ResearchConceptsNociplastic painPainful neuropathyPain patientsHealthy controlsRare variantsChronic neuropathic painChronic pain disordersChronic widespread painChronic pain patientsMolecular profilePainless neuropathyNeuropathic painPain disordersWidespread painChronic painPatient's molecular profileIndependent cohortPainPatientsClinical diagnosisDisease riskNeuropathyTRPA1 variantsNew risk genesPain genes
2022
Does gabapentin provide benefit for patients with knee OA? A benefit-harm and cost-effectiveness analysis
Bensen G, Rogers A, Leifer V, Edwards R, Neogi T, Kostic A, Paltiel A, Collins J, Hunter D, Katz J, Losina E. Does gabapentin provide benefit for patients with knee OA? A benefit-harm and cost-effectiveness analysis. Osteoarthritis And Cartilage 2022, 31: 279-290. PMID: 36414225, PMCID: PMC9892279, DOI: 10.1016/j.joca.2022.07.013.Peer-Reviewed Original ResearchConceptsQuality-adjusted life yearsIncremental cost-effectiveness ratioKnee osteoarthritisUsual careNociplastic painCumulative quality-adjusted life yearsMore quality-adjusted life yearsNeuropathic pain syndromesDirect medical costsOsteoarthritis Policy ModelLifetime direct medical costsCost-effectiveness ratioCost-effectiveness analysisOA carePainDETECT questionnairePain syndrome
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply